337: Eli Lilly CEO on Trump, obesity drugs, and a guidance miss
The Readout Loud
Pursuing Trillion-Dollar Valuations in Healthcare
This chapter explores Eli Lilly's pursuit of becoming the first healthcare company with a trillion-dollar market valuation, delving into the complexities of the pharmaceutical sector. It highlights the significance of innovation, the lengthy product development process, and the company's overall growth prospects.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
